SCHEMBL693773

SCHEMBL693773

Fc1ccc(-c2nc3c[c]ccc3[nH]2)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 6/20 0.43
HPGD P15428 4/20 0.43
HSD17B10 Q99714 3/20 0.43
CYP3A4 P08684 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
SMN1; SMN2 Q16637 6/20 0.42
KCNH2 Q12809 2/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
POLB P06746 2/20 0.38
PKM P14618 5/20 0.37
MAPT P10636 3/20 0.37
NFKB1 P19838 2/20 0.37
GMNN O75496 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL695765 0.83 KDM4E (0.61) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
SCHEMBL16719399 0.81 GAA (0.51) ALDH1A1KDM4EHPGDHSD17B10NPC1
SCHEMBL9033788 0.80 NPC1 (0.53) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
SCHEMBL3336689 0.78 NPC1 (0.68) ALDH1A1KDM4EHPGDHSD17B10NPC1
SCHEMBL24075329 0.78 KDM4E (0.68) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
SCHEMBL16719328 0.77 MTOR (0.39) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
SCHEMBL704211 0.77 NPBWR1 (0.51) KCNH2HDAC6
SCHEMBL694906 0.76 NPC1 (0.62) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
SCHEMBL8671614 0.76 QPCT (0.38) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
SCHEMBL16720914 0.75 GAA (0.51) ALDH1A1KDM4EHPGDHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed